Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record.

Nonalcoholic fatty liver disease: What nurses need to know

·2020·Nursing

Abstract

INSTRUCTIONS Nonalcoholic fatty liver disease: What nurses need to know TEST INSTRUCTIONS Read the article. The test for this CE activity is to be taken online at www.nursingcenter.com/CE/nursing. You'll need to create (it's free!) and log in to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you. There's only one correct answer for each question. A passing score for this test is 14 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost. For questions, contact Lippincott Professional Development: 1-800-787-8985. Registration deadline is March 4, 2022. PROVIDER ACCREDITATION Lippincott Professional Development will award 1.5 contact hours and 0.5 pharmacology credits for this continuing nursing education activity. Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours, and the District of Columbia, Georgia, and Florida CE Broker #50-1223. Payment: The registration fee for this test is $17.95. Nonalcoholic fatty liver disease: What nurses need to know GENERAL PURPOSE: To provide an overview of NAFLD. LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Describe risk factors for NAFLD. 2. List the clinical manifestations of NAFLD. 3. Outline nursing interventions for patients with NAFLD. What distinguishes NASH from NAFLD? elevated liver enzymes significant hepatic inflammation excess hepatic fat Which is a diagnostic criterion for metabolic syndrome? FPG of 100 mg/dL or more serum triglycerides less than 150 mg/dL without drug therapy waist circumference of 88 cm or more in men The loss of hepatocytes associated with the aging process leads to reductions in serum levels of alkaline phosphatase. aminotransferase. albumin. Along with cardiovascular disease, which is a common cause of death in patients with NAFLD and NASH? malignancies diabetes mellitus pneumococcal disease Which of the following is an independent predictor of advanced liver fibrosis in patients with NAFLD? OSA IR POS A medication known to trigger NAFLD is ezetimibe. pioglitazone. amiodarone. Individuals of which ethnicity are more susceptible to NAFLD? Asian Hispanic African American What is the most common initial manifestation of NAFLD? fatigue jaundice abdominal pain The preferred initial radiologic study to assess for fatty infiltration of the liver is computed tomography. MRE. transabdominal liver ultrasound. What is used to assess the extent of liver stiffness? liver fibrosis panel TE liver biopsy The NAS assigns a score of 0 to 2 to steatosis. lobular inflammation. hepatocellular ballooning. Fibrosis spreading and forming bridges with other fibrotic liver areas is staged as F2. F3. F4. To resolve mild-to-moderate fibrosis, the AASLD recommends that patients reduce body weight by 5%. 10%. 15%. Nutritional recommendations for patients with NAFLD include having 40% to 50% of total dietary intake comprised of low-fiber foods. carbohydrates. lean proteins. Fatty liver is caused by an accumulation of low-density lipoprotein cholesterol. HDL cholesterol. triglycerides. Which cholesterol-lowering medication has been shown to significantly improve visceral fat areas and levels of fasting insulin, triglycerides, and cholesterol? ezetimibe gemfibrozil rosuvastatin Which of the following supplements does the AASLD recommend considering for adults without diabetes who have biopsy-proven NASH? vitamin A vitamin D vitamin E A diet rich in which of the following has been proven beneficial for patients with NAFLD and NASH? low-fat dairy products whole grains lean protein Up to what percentage of patients with NAFLD will progress to NASH? 5% 10% 20%

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.nurse.0000656496.00204.01

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 179

Metadata

Venue
Nursing
Published
2020-03
Volume
50
Issue
3
Pages
39-40
ISSN
0360-4039 (ISSN-L)
OpenAlex
W294978683
Cited by
179
References
0
FWCI
6.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonalcoholic fatty liver disease: What nurses need to know. https://app.cochat.ai/papers/10.1097/01.nurse.0000656496.00204.01
The paper
Nonalcoholic fatty liver disease: What nurses need to know. (2020). Nursing. https://doi.org/10.1097/01.nurse.0000656496.00204.01

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.